ZATA PHARMACEUTICALS INC has a total of 16 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are JANSSEN PRODUCTS LP, ALCHEMIA PTY LTD and NUCLEIC ACID RESEARCH INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 3 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology | |
#4 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Sugars | |
#4 | Object sterilising | |
#5 | Heterocyclic compounds | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Tabatadze David R | 12 |
#2 | Yanachkov Ivan | 7 |
#3 | Tabatadze David | 4 |
#4 | Yanachkov Ivan B | 3 |
#5 | Zavizion Boris V | 2 |
#6 | Zamecnik Paul C | 2 |
#7 | Guranowski Andrzej | 1 |
#8 | Pierson Karen | 1 |
#9 | Raychowdhury Malay K | 1 |
#10 | Blackburn Michael G | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020086970A1 | Detection method for natural and modified small nucleic acids | |
CA3107314A1 | Method for pathogens, microorganisms, and parasites inactivation | |
AU2015350001A1 | Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compounds | |
WO2015073622A1 | Aziridinyl containing compounds and methods of inactivating nucleic acid molecules comprising the same | |
WO2010056795A1 | Novel synthetic dinucleoside polyphosphate analogs and their use as new therapeutic and/or diagnostic modalities | |
US2010204310A1 | New modalities for treatment of drug-resistant tuberculosis and other diseases |